AzTrials
AzTrials

Spinal Cord InjuryNCT07019207

Virtual Reality Dual Task Training in SCI: Effects on Cognition and Cortical Activation

A study testing VR-Based Dual-Task Training with Motor Imagery, VR-Based Dual-Task Training without Motor Imagery and Proprioceptive Neuromuscular Facilitation in people with Spinal Cord Injury, run by Istinye University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Spinal cord injury (SCI) is a severe neurological condition characterized by the loss of motor and sensory functions due to damage in the spinal cord or the nerves branching from it. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Spinal Cord Injury
What is being tested?
VR-Based Dual-Task Training with Motor Imagery, VR-Based Dual-Task Training without Motor Imagery and Proprioceptive Neuromuscular Facilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteTurkey (Türkiye)
Study dates
16 Jun 2025to 26 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Being between 18-60 years old
  • Having full or partial paraplegia
  • Having an injury level of T1 or below
  • Having at least 90° active shoulder flexion and abduction
  • Having at least 3 months since the injury

Who cannot join

  • Musculoskeletal pain greater than 5 out of 10 on the Visual Analog Scale
  • Patients who cannot sit in a chair for at least 30 minutes
  • Presence of deformities or color changes in joints that prevent upper extremity movements
  • Patients who have had fractures or operations on the upper extremity within the last 6 months
  • History of head trauma
  • Presence of a disease known to affect cognitive impairment
Show all 13Show fewer
  • Severe deafness, blindness or significant physical illnesses that cause communication disorders and prevent patients from participating in the study
  • Presence of any known cardiovascular disease
  • Conditions in which virtual reality glasses are contraindicated (epilepsy; vertigo and similar severe movement disorders)
  • Patients with a history of stroke or progressive neurodegenerative disease
  • Patients with neuromuscular disease
  • Patients with uncontrolled epilepsy
  • Concurrent participation in other studies or treatments

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Turkey (Türkiye)1 site
  • Hüsnü Ayık Care Center

    Istanbul, Beylikdüzü, 34528

    MUHAMMED OYMAK, +90 5312271870, iletisim@tofd.org.tr

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality-Based Dual-Task Training on Cognition, Cortical Activation, and Functional Level in Patients With Spinal Cord Injury

Spinal cord injury (SCI) is a severe neurological condition characterized by the loss of motor and sensory functions due to damage in the spinal cord or the nerves branching from it. Although studies investigating cognitive function after SCI are limited, it has been reported that up to 60% of individuals experience cognitive impairments. Because of impaired motor control, patients may need to invest more cognitive effort to perform even simple movements. This situation can negatively affect their ability to carry out multiple tasks at the same time and to respond effectively to environmental threats while walking, which may increase their risk of falling. Although the presence of cognitive changes after SCI is recognized in the literature, there are only a few studies examining the effects of rehabilitation on cortical activation, highlighting the need for innovative approaches to improve both motor and cognitive functions. The aim of this randomized controlled study is to investigate the effects of virtual reality (VR)-based dual-task training, both with and without motor imagery, on cortical activation, cognition, and functional level in individuals with SCI. Participants who meet the inclusion criteria will be recruited from the Turkish Spinal Cord Paralytics Association and will be randomly assigned to one of three groups: (1) a VR-based dual-task training group including motor imagery (n=15), (2) a VR-based dual-task training group without motor imagery (n=15), and (3) a control group (n=15). After obtaining informed consent and recording demographic data, pre-treatment (T0) and post-treatment (T1) assessments will be conducted. Cortical activation will be measured using functional near-infrared spectroscopy (fNIRS), grip strength with a Jamar hand dynamometer, upper extremity functional level with the Fugl-Meyer Assessment, sitting balance with the Modified Functional Reach Test, cognitive status with the Montreal Cognitive Assessment (MoCA), and occupational performance with the Canadian Occupational Performance Measure (COPM). Patient satisfaction and general health status will also be recorded. In addition to upper extremity strengthening exercises, patients in the VR groups will perform a cognitive-motor dual-task game developed by the researchers, which is played with VR glasses. The motor imagery group will complete the tasks while visualizing themselves standing and walking, while the other group will play the same game without walking imagery, from a wheelchair perspective. The game will involve motor tasks such as crossing the street between moving cars and walking on the sidewalk without bumping into people, as well as cognitive tasks based on the Stroop test, which will become progressively more difficult through three stages. Completing all stages will take approximately 20 minutes. Patients in the control group will only receive upper extremity strengthening exercises. The intervention will last for 12 sessions, conducted twice a week. The findings of this study are expected to emphasize the importance of simultaneous motor and cognitive rehabilitation in individuals with SCI and to contribute scientifically to the use of VR-supported innovative approaches in rehabilitation practices.

Being tested
VR-Based Dual-Task Training with Motor Imagery, VR-Based Dual-Task Training without Motor Imagery, Proprioceptive Neuromuscular Facilitation
Keywords
Dual-task, Virtual Reality, Cognition, Spinal Cord Injuries, Cortical Activation
Medical subject headings
Spinal Cord Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR-Based Dual-Task Training with Motor ImageryBehavioural

    Participants will perform the game consisting of 3 different stages during one session. The motor task will include crossing the street between cars and walking on the sidewalk without hitting people. The difference between the stages will be the cognitive task, which becomes more difficult with each stage. The cognitive task in the first stage of the game will involve the colors that the patient will see and the simultaneous sound of the colors. The cognitive task in the second stage of the game will involve writing the names of some colors with black paint and reading them simultaneously. In the third stage of the game, the patient will see color names written with some colors. Every 5 seconds a new match will appear and the number of errors made during the matches will be recorded. In addition, upper extremity strengthening with PNF methods such as hold relaxation, rhythmic stabilization and repetitive stretches will be studied.

  • VR-Based Dual-Task Training without Motor ImageryBehavioural

    The difference of this group from the first group is that they will see that they provide mobility with a wheelchair instead of walking, which is a motor task. In this case, there will be no motor imagery of walking. Simultaneously with the game, an environment where the wheelchair can move safely will be created in order to prevent symptoms such as dizziness and nausea in the patients and the wheelchair will be moved in this environment by the researcher. The difference between the stages will be the cognitive task that becomes more difficult at each stage and it will take a total of 20 minutes to complete all stages of the game. In addition, upper extremity strengthening will be practiced with PNF methods of hold and relax, rhythmic stabilization and repetitive stretches.

  • Proprioceptive Neuromuscular FacilitationBehavioural

    The patients in the group will be applied only the resistance band strengthening methods including the upper extremity proprioceptive neuromuscular facilitation (PNF) patterns and methods applied as standard in rehabilitation. Strengthening will be worked on in all upper extremity PNF patterns using the resistance band with the PNF methods of hold-relax, rhythmic stabilization and repetitive stretching.

Study groups in NCT07019207
Study groupRoleWhat they receive
VR-Based Dual-Task Training with Motor Imagery GroupExperimentalIn addition to the treatment to be applied to the participants in this group for upper extremity strengthening, they will complete a dual-task game designed by the researchers and involving cognitive-motor activity-based motor imagery that can be used with virtual reality glasses. Patients in this group will perform motor tasks during the game by seeing themselves standing and walking. Simultaneously with the game, an environment where the wheelchair can move safely will be created to prevent symptoms such as dizziness and nausea in patients and the wheelchair will be moved by the researcher in this environment. Participants will perform the game consisting of 3 different stages during one session. The motor task will be the same in all phases, the cognitive task will change.
Receives: Behavioral: VR-Based Dual-Task Training with Motor Imagery
VR-Based Dual-Task Training without Motor Imagery GroupExperimentalParticipants in this group will perform upper extremity strengthening exercises, similar to the other groups. Additionally, they will engage in a game that is identical in design to that used in the first group, but without incorporating motor imagery. The key distinction from the first group is that during the game, participants will achieve mobility via a wheelchair instead of performing the motor task of walking. Consequently, no motor imagery related to walking will be involved. To prevent symptoms such as dizziness and nausea during the game, a safe environment will be created in which the wheelchair can move securely. The wheelchair will be moved within this environment by the researcher. The main difference between the stages will be the progressively increasing difficulty of the cognitive tasks.
Receives: Behavioral: VR-Based Dual-Task Training without Motor Imagery
Control GroupActive comparatorThis group is designated as the control group. Participants will receive only standard rehabilitation interventions, consisting of resistance band strengthening exercises based on proprioceptive neuromuscular facilitation (PNF) patterns and techniques commonly used in clinical practice.
Receives: Behavioral: Proprioceptive Neuromuscular Facilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cortical Hemodynamics (Functional Near-Infrared Spectroscopy)

    A portable functional near-infrared spectroscopy (fNIRS) system (Brite MKIII, Artinis, The Netherlands) will be used to monitor hemodynamic changes during patients' cognitive tasks. Optode placement will be based on previous studies and Brodmann areas. Data will be simultaneously collected and analyzed using OxySoft software. The device includes ten emitters and eight detectors arranged in a 2 × 12 channel layout, covering cortical regions related to upper extremity representation. Channels will be symmetrically distributed across hemispheres. The emitter-detector distance will be set at 30 mm, and light wavelengths of 763 nm and 842 nm will be used. HbO₂ concentrations in regions of interest (PFC, SFC, SMA, and PMC) will be measured. ΔHbO₂, ΔHbR, and ΔHbT values will be recorded per channel as time-series data in units of μmol/L.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

  2. Upper Extremity Functional Level (Fugl-Meyer Motor Assessment Scale - Upper Extremity (FMA))

    The scale consists of five sections: motor function (upper and lower extremities), sensory function, balance, joint range of motion, and joint pain; however, the motor function assessment is the most commonly used section. It includes 33 items, each scored on a three-point ordinal scale based on the participant's ability to perform the task. For the upper extremity motor function, a participant can achieve a maximum score of 66. Higher scores indicate better motor function.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

  3. Cognition (Montreal Cognitive Assessment Test (MoCA))

    MoCA consists of nine subtests. It assesses multiple cognitive domains, including executive functions (e.g., trail making), visuospatial abilities (clock drawing task and three-dimensional cube copying), attention, concentration, working memory, language (e.g., a three-item naming task with low-familiarity animals), short-term memory, and orientation to time and place. These correspond to the following MoCA subtests: trail making, visuoconstructional skills, naming, attention, sentence repetition, verbal fluency, abstraction, delayed recall, and orientation. A score of 21 or higher on the scale is considered normal.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

  4. Sitting Balance (Modified Functional Reach Test)

    The test is conducted with the individual seated in a standard wheelchair with footrests. The measuring rod is mounted on the wall at the level of the acromion process of the shoulder. To measure reach, the ulnar styloid process is used as the anatomical landmark. The participant is asked to flexion their shoulder to 90 degrees for the first reading, then to reach as far as possible without any support for the second reading, and finally to return to the starting position. The difference between the two readings is recorded. Each participant is given three trials, and the average is calculated.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

Secondary outcomes (3)
  1. Gross grip strength (Jamar hand dynamometer)

    Standard grip strength is measured using the Jamar hand dynamometer (Pro Med Products, Atlanta, GA) in the standardized test position recommended by the American Society of Hand Therapists, with the patient seated, the arm positioned at the side of the body, and the elbow flexed at 90 degrees. Participants are instructed to squeeze the dynamometer with maximum effort and then fully relax. This procedure is repeated three times for both the right and left hands, and the average values are calculated in kilograms.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

  2. Occupational Performance (Canadian Activity Performance Scale (COPM))

    The Canadian Occupational Performance Measure (COPM) is a semi-structured, client-centered scale designed to detect changes over time in self-reported occupational performance. It consists of five steps and three scoring phases: (1) The individual identifies occupations in the areas of self-care, productivity, and leisure, rating their importance on a scale from 1 (not important at all) to 10 (extremely important). (2) Using these ratings, the individual selects the five most important occupations. (3) The individual then rates their performance and satisfaction with performance in these selected occupations on a scale from 1 to 10. Two distinct dimensions-Performance and Satisfaction-are evaluated. Each dimension is scored from 1 to 10, with a maximum score of 10 for each. Higher scores indicate better performance and greater satisfaction.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

  3. Patient Satisfaction (Patient Satisfaction Short Evaluation Form)

    The level of patient satisfaction with the treatment they receive is a critical variable for their adherence to treatment and the continuity of their well-being. The scale developed to measure this can yield scores ranging from 0 to 28. Higher scores indicate a greater level of dissatisfaction.

    Measured: Pre-treatment (Week 0) and after treatment (Week 6)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2025
  2. Study start16 Jun 2025 (estimated)
  3. Primary completion25 Jan 2026 (estimated)
  4. Study completion26 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants who meet the inclusion criteria will be randomly assigned to one of three groups: a VR-based dual-task training with motor imagery group, a VR-based dual-task training without motor imagery group and a control group. Each arm will receive a distinct intervention protocol concurrently over the same study period.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07019207
Sponsor's protocol ID
IstinyeUni-OCAKMAK-001
Status last verified
May 2025
First submitted
3 Jun 2025
Last updated
13 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study will share de-identified, summary-level outcome data, including group-level means, standard deviations, effect sizes, and p-values derived from statistical analyses. These data will be provided to support transparency and allow for interpretation of the study findings.

Publications

  • Cheng C, Liu T, Zhang B, Wu X, Song Z, Zhao Z, Ren X, Zhao M, Su Y, Wang J. Effects of robot-assisted hand function therapy on brain functional mechanisms: a synchronized study using fNIRS and sEMG. Front Med (Lausanne). 2024 Oct 31;11:1411616. doi: 10.3389/fmed.2024.1411616. eCollection 2024.

    PubMed 39544380
  • Zhou Y, Zhao Y, Xiang Z, Yan Z, Shu L, Xu X, Zhang L, Tian X. A dual-task-embedded virtual reality system for intelligent quantitative assessment of cognitive processing speed. Front Hum Neurosci. 2023 Mar 30;17:1158650. doi: 10.3389/fnhum.2023.1158650. eCollection 2023.

    PubMed 37063104
  • Chiaravalloti ND, Weber E, Wylie G, Dyson-Hudson T, Wecht JM. The impact of level of injury on patterns of cognitive dysfunction in individuals with spinal cord injury. J Spinal Cord Med. 2020 Sep;43(5):633-641. doi: 10.1080/10790268.2019.1696076. Epub 2019 Dec 20.

    PubMed 31859606

Questions about this trial

What is this clinical trial studying?

A study testing VR-Based Dual-Task Training with Motor Imagery, VR-Based Dual-Task Training without Motor Imagery and Proprioceptive Neuromuscular Facilitation in people with Spinal Cord Injury, run by Istinye University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact ÖZGE ÇAKMAK (+905359463069, ozgeckmakk@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cortical Hemodynamics (Functional Near-Infrared Spectroscopy) (time frame: Pre-treatment (Week 0) and after treatment (Week 6)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07019207, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in